Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report
Submitted: 20 May 2023
Accepted: 30 June 2023
Published: 17 July 2023
Accepted: 30 June 2023
Abstract Views: 930
PDF: 517
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- L.B. Santos, J. Rigueira, A.P. Vilas, Infliximab in the treatment of Budd-Chiari syndrome in Behçet’s disease , Reumatismo: Vol. 71 No. 3 (2019)
- A.C.C.D. Baccaro, G.L. Behrens Pinto, R.C.S. Carboni, S.K. Shinjo, The clinical manifestations at the onset of antisynthetase syndrome: A chameleon with multiple faces , Reumatismo: Vol. 72 No. 2 (2020)
- C.S.R. Araujo, R. Miossi, F.H.C. De Souza, M.D. Costa, A.M.S. da Silva, E.D. Campos, E. Zanoteli, S.K. Shinjo, Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature , Reumatismo: Vol. 73 No. 2 (2021)
- G. Fabbriciani, A. Colombini, C. Messina, G. Adami, Novel genetic mutation associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome treated with denosumab: a case report , Reumatismo: Vol. 76 No. 2 (2024)
- A. Lo Monaco, D. Santilli, F. Trotta, Anterior chest wall examination reviewed , Reumatismo: Vol. 54 No. 1 (2002)
- A. Cauli, G. Porru, A. Vacca, A. Mameli, V. Ibba, V. Mura, M. Piga, A. Mathieu, IFN-αα induced psoriatic arthritis and HCV-related liver cirrhosis. Therapeutic options and patient’s opinion , Reumatismo: Vol. 60 No. 1 (2008)
- G.L. Erre, G. Passiu, Antioxidant effect of Iloprost: current knowledge and therapeutic implications for systemic sclerosis , Reumatismo: Vol. 61 No. 2 (2009)
- S. Perrot, If fibromyalgia did not exist, we should have invented it. A short history of a controversial syndrome , Reumatismo: Vol. 64 No. 4 (2012)
- S. Tanwar, B. Mattoo, U. Kumar, R. Dada, R. Bhatia, Does human serotonin-1A receptor polymorphism (rs6295) code for pain and associated symptoms in fibromyalgia syndrome? , Reumatismo: Vol. 73 No. 1 (2021)
- N. Sanghavi, B. Ayesha, Anti-N-methyl-d-aspartate receptor encephalitis: mimicker of lupus and multiple sclerosis , Reumatismo: Vol. 75 No. 4 (2023)
<< < 23 24 25 26 27 28 29 30 31 32 > >>
You may also start an advanced similarity search for this article.